The Scripps Research Institute selects Zeidler Partnership to design new Florida campus.

The Scripps Research Institute today selected Zeidler Partnership/Bohlin Cywinski Jackson, including 10 Florida-based partners, for final negotiations to design the new US$137 million Scripps Florida campus in Palm Beach County.

The two teams were selected from four design and four project manager finalists chosen by a steering committee of Scripps Research senior executives, scientists, board members, and local Palm Beach experts. The finalists were chosen from 23 design and architecture firms and 16 project management companies that submitted proposals to Scripps Research on February 18 in response to published Requests for Proposals.

Scripps Florida, a 364,000 square foot, state-of-the-art biomedical research facility, will be built on 100 acres of undeveloped land west of I-95 off of PGA Boulevard and bordered by Seminole/Pratt Whitney Road. The facility will focus on basic biomedical science, drug discovery, and technology development. Palm Beach County is providing an economic package that includes the land, US$137 million toward construction of the permanent facility and related costs, and costs for temporary facilities for Scripps scientists.

The start-up costs of Scripps Florida, a division of The Scripps Research Institute headquartered in La Jolla, California, are supported by a one-time $310 million appropriation of federal economic development funds made by the State of Florida at the request of Governor Jeb Bush. Scripps Florida is expected to attract other research facilities, and biotechnology and pharmaceutical firms, as well as residential, commercial, recreational, educational, and cultural development to the surrounding area.

Planning, development, and construction of the new campus are scheduled to begin as soon as contracts are finalized. The campus is expected to open in late 2006.

The Scripps Research Institute of La Jolla, California, and Palm Beach County, Florida, is one of the world’s largest, private, non-profit biomedical research organizations.